Loading…
Impaired lung function in multiple sclerosis: a single-center observational study in 371 persons
Introduction Abnormal lung function in people with multiple sclerosis (PwMS) could be considered as the result of muscle weakness or MS-specific structural central nervous system (CNS) abnormalities as a precipitant factor for the worsening of motor impairment or cognitive symptoms. Methods This is...
Saved in:
Published in: | Neurological sciences 2023-12, Vol.44 (12), p.4429-4439 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Introduction
Abnormal lung function in people with multiple sclerosis (PwMS) could be considered as the result of muscle weakness or MS-specific structural central nervous system (CNS) abnormalities as a precipitant factor for the worsening of motor impairment or cognitive symptoms.
Methods
This is a cross-sectional observational study in PwMS. Forced spirometry was conducted, and normative metrics of forced vital capacity (FVC), forced expiratory volume in the first second (FEV
1
), and the relation FEV1/FVC were calculated. Qualitative and quantitative brain magnetic resonance imaging (MRI) examinations were carried out.
Results
A total of 371 PwMS were included in the study. Of those, 196 (53%) had RRMS, 92 (25%) SPMS, and 83 (22%) PPMS. Low FVC and FEV
1
was present in 16 (8%), 16 (19%), and 23 (25%) of the patients in the RRMS, PPMS, and SPMS, respectively. PwMS with T2-FLAIR lesions involving the corpus callosum (CC) had a significantly higher frequency of abnormally low FVC and FEV
1
(OR 3.62; 95% CI 1.33–9.83;
p
= 0.012) than patients without lesions in that region. This association remained significant in the RRMS group (OR 10.1; 95% CI 1.3–67.8;
p
0.031) when the model excluded PPMS and SPMS. According to our study, for every increase of 1
z
score of FVC, we observed an increase of 0.25 cm
3
of hippocampal volume (
β
0.25; 95% CI 0.03–0.47;
p
0.023) and 0.43 cm
3
of left hippocampus volume (
β
0.43; 95% CI 0.16–0.71;
p
0.002).
Conclusions
We observed an incremental prevalence of abnormally low pulmonary function tests that parallels a sequence from more early relapsing courses to long-standing progressive courses (RRMS to PPMS or SPMS). |
---|---|
ISSN: | 1590-1874 1590-3478 |
DOI: | 10.1007/s10072-023-06914-6 |